{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:14:06Z","timestamp":1792012446528,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02560-y","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:04:50Z","timestamp":1769753090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6"],"prefix":"10.1186","volume":"25","author":[{"given":"Ashuai","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songsong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingliang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"1","key":"2560_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comp\u00e9rat EM, Cowan NC, Gakis G, Hern\u00e1ndez V, Linares Espin\u00f3s E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskim\u00e4e E, Ribal MJ, Van Der Heijden AG. European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol"},{"issue":"5","key":"2560_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC Van Hoogstraten","year":"2023","unstructured":"Van Hoogstraten LMC, Vrieling A, Van Der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"2560_CR3","doi-asserted-by":"crossref","unstructured":"Leyderman M, Chandrasekar T, Grivas P, Li R, Bhat S, Basnet A, et al. Metastasis development in non-muscle-invasive bladder cancer. Nat Rev Urol. 2025;22(6):375\u201386.","DOI":"10.1038\/s41585-024-00963-y"},{"issue":"4","key":"2560_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.eururo.2020.06.048","volume":"78","author":"AG Robertson","year":"2020","unstructured":"Robertson AG, Groeneveld CS, Jordan B, Lin X, Mclaughlin KA, Das A, Fall LA, Fantini D, Taxter TJ, Mogil LS, Lindskrog SV, Dyrskj\u00f8t L, Mcconkey DJ, Svatek RS, De Reyni\u00e8s A, Castro MA, Meeks JJ. Identification of differential tumor subtypes of T1 bladder cancer. Eur Urol. 2020;78(4):533\u20137.","journal-title":"Eur Urol"},{"issue":"34","key":"2560_CR5","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1200\/JCO.23.02510","volume":"42","author":"DM Dahl","year":"2024","unstructured":"Dahl DM, Rodgers JP, Shipley WU, Michaelson MD, Wu CL, Parker W, Jani AB, Cury FL, Hudes RS, Michalski JM, Hartford AC, Song D, Citrin DE, Karrison TG, Sandler HM, Feng FY, Efstathiou JA. Bladder-Preserving trimodality treatment for High-Grade T1 bladder cancer: results from phase II protocol NRG Oncology\/RTOG 0926. J Clin Oncol. 2024;42(34):4095\u2013102.","journal-title":"J Clin Oncol"},{"key":"2560_CR6","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, Mo Q, Zhao X, Fan Q, Deng F, Han C, Tan W. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2560_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-022-01517-9","volume":"21","author":"ZD Shi","year":"2022","unstructured":"Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, Qin JX, Wang GY, Zhang XM, Xia T, Liang Q, Zhao Y, Li R, Zhang SQ, Zhang JH, Chen JG, Wang GC, Chen ZS, Han CH. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022;21(1):37.","journal-title":"Mol Cancer"},{"issue":"1","key":"2560_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14(1):91.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2560_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2017.01.023","volume":"65","author":"C Ziegenhain","year":"2017","unstructured":"Ziegenhain C, Vieth B, Parekh S, Reinius B, Guillaumet-Adkins A, Smets M, Leonhardt H, Heyn H, Hellmann I, Enard W. Comparative analysis of Single-Cell RNA sequencing methods. Mol Cell. 2017;65(4):631\u2013e434.","journal-title":"Mol Cell"},{"issue":"6","key":"2560_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41573-023-00688-4","volume":"22","author":"B Van De Sande","year":"2023","unstructured":"Van De Sande B, Lee JS, Mutasa-Gottgens E, Naughton B, Bacon W, Manning J, Wang Y, Pollard J, Mendez M, Hill J, Kumar N, Cao X, Chen X, Khaladkar M, Wen J, Leach A, Ferran E. Applications of single-cell RNA sequencing in drug discovery and development. Nat Rev Drug Discov. 2023;22(6):496\u2013520.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2560_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, Wu X, Wang H, Yu J, Li Y, Li X, Li G, Zeng Z, Tan Y, Xiong W. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021;40(1):81.","journal-title":"J Exp Clin Cancer Res"},{"issue":"14","key":"2560_CR12","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.7150\/ijbs.61717","volume":"17","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Liu S, Liu C, Yang J, Lin Q, Zheng S, Chen C, Zhou Q, Chen R. Single-cell RNA sequencing reveals Spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor. Int J Biol Sci. 2021;17(14):3760\u201375.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"2560_CR13","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1007\/s00345-020-03086-2","volume":"38","author":"Y Sun","year":"2020","unstructured":"Sun Y, Zhu D, Xing H, Hou Y, Liu Y. Screening of characteristic biomolecules related to bladder cancer based on construction of CeRNA regulation network. World J Urol. 2020;38(11):2835\u201347.","journal-title":"World J Urol"},{"issue":"5","key":"2560_CR14","doi-asserted-by":"publisher","first-page":"e17198","DOI":"10.15252\/emmm.202217198","volume":"15","author":"Z Huang","year":"2023","unstructured":"Huang Z, Shen S, Han X, Li W, Luo W, Lin L, Xu M, Wang Y, Huang W, Wu G, Liang G. Macrophage DCLK1 promotes atherosclerosis via binding to IKK\u03b2 and inducing inflammatory responses. EMBO Mol Med. 2023;15(5):e17198.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"2560_CR15","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.3892\/or.2017.5974","volume":"38","author":"D Kawamura","year":"2017","unstructured":"Kawamura D, Takemoto Y, Nishimoto A, Ueno K, Hosoyama T, Shirasawa B, Tanaka T, Kugimiya N, Harada E, Hamano K. Enhancement of cytotoxic effects of gemcitabine by Dclk1 Inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. Oncol Rep. 2017;38(5):3238\u201344.","journal-title":"Oncol Rep"},{"key":"2560_CR16","doi-asserted-by":"crossref","unstructured":"Cao Z, Weygant N, Chandrakesan P, Houchen CW, Peng J, Qu D. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment. Cancers (Basel). 2020;12(12):1\u201317.","DOI":"10.3390\/cancers12123801"},{"issue":"3","key":"2560_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/carcin\/bgz157","volume":"41","author":"S Makino","year":"2020","unstructured":"Makino S, Takahashi H, Okuzaki D, Miyoshi N, Haraguchi N, Hata T, Matsuda C, Yamamoto H, Mizushima T, Mori M, Doki Y. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer. Carcinogenesis. 2020;41(3):303\u201312.","journal-title":"Carcinogenesis"},{"key":"2560_CR18","doi-asserted-by":"publisher","first-page":"101317","DOI":"10.1016\/j.tranon.2021.101317","volume":"17","author":"Y Ge","year":"2022","unstructured":"Ge Y, Liu H, Zhang Y, Liu J, Yan R, Xiao Z, Fan X, Huang X, An G. Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma. Transl Oncol. 2022;17:101317.","journal-title":"Transl Oncol"},{"issue":"1","key":"2560_CR19","first-page":"23","volume":"10","author":"C Mohammadi","year":"2021","unstructured":"Mohammadi C, Mahdavinezhad A, Saidijam M, Bahreini F, Sedighi Pashaki A, Gholami MH, Najafi R. DCLK1 Inhibition sensitizes colorectal cancer cells to radiation treatment. Int J Mol Cell Med. 2021;10(1):23\u201333.","journal-title":"Int J Mol Cell Med"},{"key":"2560_CR20","doi-asserted-by":"publisher","first-page":"122294","DOI":"10.1016\/j.lfs.2023.122294","volume":"336","author":"L Ye","year":"2024","unstructured":"Ye L, Liu B, Huang J, Zhao X, Wang Y, Xu Y, Wang S. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers. Life Sci. 2024;336:122294.","journal-title":"Life Sci"},{"issue":"2","key":"2560_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jcmgh.2022.10.013","volume":"15","author":"R Yan","year":"2023","unstructured":"Yan R, Li J, Xiao Z, Fan X, Liu H, Xu Y, Sun R, Liu J, Yao J, An G, Shi Y, Ge Y. DCLK1 suppresses Tumor-Specific cytotoxic T lymphocyte function through recruitment of MDSCs via the CXCL1-CXCR2 axis. Cell Mol Gastroenterol Hepatol. 2023;15(2):463\u201385.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"20","key":"2560_CR22","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/onc.2013.210","volume":"33","author":"P Chandrakesan","year":"2014","unstructured":"Chandrakesan P, Roy B, Jakkula LU, Ahmed I, Ramamoorthy P, Tawfik O, Papineni R, Houchen C, Anant S, Umar S. Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. Oncogene. 2014;33(20):2639\u201354.","journal-title":"Oncogene"},{"issue":"4","key":"2560_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2560_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"7","key":"2560_CR25","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, Rodman C, Luo CL, Mroz EA, Emerick KS, Deschler DG, Varvares MA, Mylvaganam R, Rozenblatt-Rosen O, Rocco JW, Faquin WC, Lin DT, Regev A, Bernstein BE. Single-Cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171(7):1611\u2013e2424.","journal-title":"Cell"},{"issue":"9","key":"2560_CR26","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.celrep.2018.02.007","volume":"22","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wang X, Wang Q, Deng Y, Li K, Zhang M, Zhang Q, Zhou J, Wang HY, Bai P, Ren Y, Zhang N, Li W, Cheng Y, Xiao W, Du HN, Cheng X, Yin L, Fu X, Lin D, Zhou Q, Zhong B. USP2a supports metastasis by tuning TGF-\u03b2 signaling. Cell Rep. 2018;22(9):2442\u201354.","journal-title":"Cell Rep"},{"issue":"1","key":"2560_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-023-02711-3","volume":"42","author":"Y Cui","year":"2023","unstructured":"Cui Y, Li J, Zhang P, Yin D, Wang Z, Dai J, Wang W, Zhang E, Guo R. B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma. J Exp Clin Cancer Res. 2023;42(1):146.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2560_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13046-024-03175-9","volume":"43","author":"H Wang","year":"2024","unstructured":"Wang H, Yao L, Chen J, Li Y, Su Z, Liu Y, Li W, Xiong Y, Gao H, Zhang X, Zhou Y. The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma. J Exp Clin Cancer Res. 2024;43(1):252.","journal-title":"J Exp Clin Cancer Res"},{"issue":"28","key":"2560_CR29","doi-asserted-by":"publisher","first-page":"e2400206","DOI":"10.1002\/advs.202400206","volume":"11","author":"J Liang","year":"2024","unstructured":"Liang J, Dai W, Liu C, Wen Y, Chen C, Xu Y, Huang S, Hou S, Li C, Chen Y, Wang W, Tang H. Gingerenone A attenuates ulcerative colitis via targeting IL-17RA to inhibit inflammation and restore intestinal barrier function. Adv Sci (Weinh). 2024;11(28):e2400206.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"2560_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41565-019-0472-4","volume":"14","author":"X Lu","year":"2019","unstructured":"Lu X, Zhu Y, Bai R, Wu Z, Qian W, Yang L, Cai R, Yan H, Li T, Pandey V, Liu Y, Lobie PE, Chen C, Zhu T. Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades. Nat Nanotechnol. 2019;14(7):719\u201327.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"2560_CR31","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.cellin.2023.100100","volume":"2","author":"K Yu","year":"2023","unstructured":"Yu K, Guo YY, Liuyu T, Wang P, Zhang ZD, Lin D, Zhong B. The deubiquitinase OTUD4 inhibits the expression of antimicrobial peptides in Paneth cells to support intestinal inflammation and bacterial infection. Cell Insight. 2023;2(3):100100.","journal-title":"Cell Insight"},{"issue":"1","key":"2560_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41467-022-28158-2","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhao Y, Yang X, Ren X, Huang S, Gong S, Tan X, Li J, He S, Li Y, Hong X, Li Q, Ding C, Fang X, Ma J, Liu N. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. Nat Commun. 2022;13(1):501.","journal-title":"Nat Commun"},{"issue":"36","key":"2560_CR33","doi-asserted-by":"publisher","first-page":"e2205091","DOI":"10.1002\/advs.202205091","volume":"9","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Huang S, Tan X, Long L, He Q, Liang X, Bai J, Li Q, Lin J, Li Y, Liu N, Ma J, Chen Y. N(6) -Methyladenosine-Modified CBX1 regulates nasopharyngeal carcinoma progression through heterochromatin formation and STAT1 activation. Adv Sci (Weinh). 2022;9(36):e2205091.","journal-title":"Adv Sci (Weinh)"},{"key":"2560_CR34","doi-asserted-by":"publisher","first-page":"1020757","DOI":"10.3389\/fgene.2022.1020757","volume":"13","author":"J Lin","year":"2022","unstructured":"Lin J, Liu L, Zheng F, Chen S, Yang W, Li J, Mo S, Zeng DY. Exploration the global single-cell ecological landscape of adenomyosis-related cell clusters by single-cell RNA sequencing. Front Genet. 2022;13:1020757.","journal-title":"Front Genet"},{"issue":"1","key":"2560_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park J, Hsueh PC, Li Z, Ho PC. Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity. Immunity. 2023;56(1):32\u201342.","journal-title":"Immunity"},{"issue":"9","key":"2560_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul M, Ohashi PS. The roles of CD8(+) T cell subsets in antitumor immunity. Trends Cell Biol. 2020;30(9):695\u2013704.","journal-title":"Trends Cell Biol"},{"issue":"17","key":"2560_CR37","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1093\/nar\/gkad631","volume":"51","author":"L Qiu","year":"2023","unstructured":"Qiu L, Xu W, Lu X, Chen F, Chen Y, Tian Y, Zhu Q, Liu X, Wang Y, Pei XH, Xu X, Zhang J, Zhu WG. The HDAC6-RNF168 axis regulates H2A\/H2A.X ubiquitination to enable double-strand break repair. Nucleic Acids Res. 2023;51(17):9166\u201382.","journal-title":"Nucleic Acids Res"},{"key":"2560_CR38","doi-asserted-by":"publisher","first-page":"907981","DOI":"10.3389\/fphar.2022.907981","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Yu M, Fu S, Liu D, Tan Y. Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases. Front Pharmacol. 2022;13:907981.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2560_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/onco.13673","volume":"26","author":"JE Amengual","year":"2021","unstructured":"Amengual JE, Lue JK, Ma H, Lichtenstein R, Shah B, Cremers S, Jones S, Sawas A. First-in-Class selective HDAC6 inhibitor (ACY-1215) has a highly favorable safety profile in patients with relapsed and refractory lymphoma. Oncologist. 2021;26(3):184\u2013e366.","journal-title":"Oncologist"},{"issue":"854","key":"2560_CR40","doi-asserted-by":"publisher","first-page":"eabq4888","DOI":"10.1126\/scisignal.abq4888","volume":"17","author":"S Afshar-Sterle","year":"2024","unstructured":"Afshar-Sterle S, Carli ALE, O\u2019keefe R, Tse J, Fischer S, Azimpour AI, Baloyan D, Elias L, Thilakasiri P, Patel O, Ferguson FM, Eissmann MF, Chand AL, Gray NS, Busuttil R, Boussioutas A, Lucet IS, Ernst M, Buchert M. DCLK1 induces a pro-tumorigenic phenotype to drive gastric cancer progression. Sci Signal. 2024;17(854):eabq4888.","journal-title":"Sci Signal"},{"issue":"1","key":"2560_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41420-021-00526-9","volume":"7","author":"BC Roy","year":"2021","unstructured":"Roy BC, Ahmed I, Stubbs J, Zhang J, Attard T, Septer S, Welch D, Anant S, Sampath V, Umar S. DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis. Cell Death Discov. 2021;7(1):169.","journal-title":"Cell Death Discov"},{"issue":"11","key":"2560_CR42","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/ijc.35365","volume":"156","author":"AG Vanan","year":"2025","unstructured":"Vanan AG, Vesal S, Seraj P, Ghezel MA, Eini P, Talebileili M, Asgari Z, Tahmasebi S, Hashemi M, Taheriazam A. DCLK1 in Gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target. Int J Cancer. 2025;156(11):2068\u201386.","journal-title":"Int J Cancer"},{"issue":"21","key":"2560_CR43","first-page":"9489","volume":"23","author":"YL Wang","year":"2019","unstructured":"Wang YL, Li Y, Ma YG, Wu WY. DCLK1 promotes malignant progression of breast cancer by regulating Wnt\/\u03b2-Catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(21):9489\u201398.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2560_CR44","doi-asserted-by":"publisher","first-page":"965730","DOI":"10.3389\/fmolb.2022.965730","volume":"9","author":"D Chhetri","year":"2022","unstructured":"Chhetri D, Vengadassalapathy S, Venkadassalapathy S, Balachandran V, Umapathy VR, Veeraraghavan VP, Jayaraman S, Patil S, Iyaswamy A, Palaniyandi K, Gnanasampanthapandian D. Pleiotropic effects of DCLK1 in cancer and cancer stem cells. Front Mol Biosci. 2022;9:965730.","journal-title":"Front Mol Biosci"},{"key":"2560_CR45","doi-asserted-by":"crossref","unstructured":"Ding L, Yang Y, Ge Y, Lu Q, Yan Z, Chen X, Du J, Hafizi S, Xu X, Yao J, Liu J, Cao Z, Weygant N. Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity. Cancers (Basel). 2021;13(22):1\u201319.","DOI":"10.3390\/cancers13225729"},{"key":"2560_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.yexmp.2019.04.015","volume":"108","author":"S Shafiei","year":"2019","unstructured":"Shafiei S, Kalantari E, Saeednejad Zanjani L, Abolhasani M, Asadi Lari MH, Madjd Z. Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas. Exp Mol Pathol. 2019;108:164\u201372.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"2560_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/17474124.2022.2020643","volume":"16","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yi J, Liu X. Roles of Dclk1 in the pathogenesis, diagnosis, prognosis and treatment of pancreatic cancer: A review. Expert Rev Gastroenterol Hepatol. 2022;16(1):13\u20139.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"2560_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12935-022-02632-9","volume":"22","author":"E Kalantari","year":"2022","unstructured":"Kalantari E, Razmi M, Tajik F, Asadi-Lari M, Ghods R, Madjd Z. Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis. Cancer Cell Int. 2022;22(1):217.","journal-title":"Cancer Cell Int"},{"key":"2560_CR49","doi-asserted-by":"crossref","unstructured":"Moore LL, Qu D, Sureban S, Mitchell S, Pitts K, Cooper N, et al. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. Int J Mol Sci. 2024;25(12):1\u201317.","DOI":"10.3390\/ijms25126481"},{"issue":"10","key":"2560_CR50","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1111\/febs.70026","volume":"292","author":"Z Chi","year":"2025","unstructured":"Chi Z, Do VQ, Kausar R, Kim HK, Nguyen NTT, Le TPH, Lee J, Baek IJ, Lee SW, Kim JH, Lee SY. HDAC6 Inhibition upregulates endothelial SOD3 expression via Sp1 acetylation and attenuates angiotensin II-induced hypertension. Febs J. 2025;292(10):2624\u201344.","journal-title":"Febs J"},{"key":"2560_CR51","doi-asserted-by":"publisher","first-page":"106622","DOI":"10.1016\/j.bioorg.2023.106622","volume":"138","author":"J Peng","year":"2023","unstructured":"Peng J, Xie F, Qin P, Liu Y, Niu H, Sun J, Xue H, Zhao Q, Liu J, Wu J. Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design. Bioorg Chem. 2023;138:106622.","journal-title":"Bioorg Chem"},{"issue":"5","key":"2560_CR52","doi-asserted-by":"publisher","first-page":"167137","DOI":"10.1016\/j.bbadis.2024.167137","volume":"1870","author":"QC Lin","year":"2024","unstructured":"Lin QC, Wang J, Wang XL, Pan C, Jin SW, Char S, Tao YX, Cao H, Li J. Hippocampal HDAC6 promotes POCD by regulating NLRP3-induced microglia pyroptosis via HSP90\/HSP70 in aged mice. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5):167137.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2560_CR53","doi-asserted-by":"publisher","first-page":"105274","DOI":"10.1016\/j.phrs.2020.105274","volume":"163","author":"S Pulya","year":"2021","unstructured":"Pulya S, Amin SA, Adhikari N, Biswas S, Jha T, Ghosh B. HDAC6 as privileged target in drug discovery: A perspective. Pharmacol Res. 2021;163:105274.","journal-title":"Pharmacol Res"},{"key":"2560_CR54","doi-asserted-by":"publisher","first-page":"111350","DOI":"10.1016\/j.intimp.2023.111350","volume":"127","author":"Y Ou","year":"2024","unstructured":"Ou Y, Shen C, Chen Z, Liu T, Peng Y, Zong D, Ouyang R. TDP43\/HDAC6\/Prdx1 signaling pathway participated in the cognitive impairment of obstructive sleep apnea via regulating inflammation and oxidative stress. Int Immunopharmacol. 2024;127:111350.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2560_CR55","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.1038\/s41467-024-52729-0","volume":"15","author":"S Sun","year":"2024","unstructured":"Sun S, Xu Z, He L, Shen Y, Yan Y, Lv X, Zhu X, Li W, Tian WY, Zheng Y, Lin S, Sun Y, Li L. Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed \u03b1-tubulin lactylation. Nat Commun. 2024;15(1):8377.","journal-title":"Nat Commun"},{"issue":"11","key":"2560_CR56","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.freeradbiomed.2012.09.023","volume":"53","author":"M K\u00e4stle","year":"2012","unstructured":"K\u00e4stle M, Woschee E, Grune T. Histone deacetylase 6 (HDAC6) plays a crucial role in p38MAPK-dependent induction of Heme oxygenase-1 (HO-1) in response to proteasome Inhibition. Free Radic Biol Med. 2012;53(11):2092\u2013101.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"2560_CR57","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41388-020-01550-2","volume":"40","author":"TQ Pham","year":"2021","unstructured":"Pham TQ, Robinson K, Xu L, Pavlova MN, Skapek SX, Chen EY. HDAC6 promotes growth, migration\/invasion, and self-renewal of rhabdomyosarcoma. Oncogene. 2021;40(3):578\u201391.","journal-title":"Oncogene"},{"key":"2560_CR58","doi-asserted-by":"crossref","unstructured":"Ferraresi A, Ghezzi I, Salwa A, Esposito A, Dhanasekaran DN, Isidoro C. NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy. Cells. 2024;13(21):1\u201320.","DOI":"10.3390\/cells13211816"},{"issue":"6","key":"2560_CR59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/jop.13326","volume":"51","author":"MO Tavares","year":"2022","unstructured":"Tavares MO, Milan TM, Bighetti-Trevisan RL, Leopoldino AM, De Almeida LO. Pharmacological Inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. J Oral Pathol Med. 2022;51(6):529\u201337.","journal-title":"J Oral Pathol Med"},{"key":"2560_CR60","doi-asserted-by":"publisher","first-page":"104880","DOI":"10.1016\/j.ebiom.2023.104880","volume":"98","author":"B Wang","year":"2023","unstructured":"Wang B, Tang C, Lin E, Jia X, Xie G, Li P, Li D, Yang Q, Guo X, Cao C, Shi X, Zou B, Cai C, Tian J, Hu Z, Li J. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe. EBioMedicine. 2023;98:104880.","journal-title":"EBioMedicine"},{"key":"2560_CR61","doi-asserted-by":"crossref","unstructured":"Bulut I, Lee A, Cevatemre B, Ruzic D, Belle R, Kawamura A, et al. Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells. Cancers (Basel). 2022;14(23):1\u201322.","DOI":"10.3390\/cancers14236014"},{"key":"2560_CR62","doi-asserted-by":"publisher","first-page":"763831","DOI":"10.3389\/fimmu.2021.763831","volume":"12","author":"P Chang","year":"2021","unstructured":"Chang P, Li H, Hu H, Li Y, Wang T. The role of HDAC6 in autophagy and NLRP3 inflammasome. Front Immunol. 2021;12:763831.","journal-title":"Front Immunol"},{"issue":"22","key":"2560_CR63","doi-asserted-by":"publisher","first-page":"e017751","DOI":"10.1161\/JAHA.120.017751","volume":"9","author":"DH Zhang","year":"2020","unstructured":"Zhang DH, Zhang JL, Huang Z, Wu LM, Wang ZM, Li YP, Tian XY, Kong LY, Yao R, Zhang YZ. Deubiquitinase Ubiquitin-Specific protease 10 deficiency regulates Sirt6 signaling and exacerbates cardiac hypertrophy. J Am Heart Assoc. 2020;9(22):e017751.","journal-title":"J Am Heart Assoc"},{"key":"2560_CR64","doi-asserted-by":"publisher","first-page":"116468","DOI":"10.1016\/j.ejmech.2024.116468","volume":"272","author":"Y Lu","year":"2024","unstructured":"Lu Y, Gao J, Wang P, Chen H, He X, Luo M, Guo Y, Li L, Zhuang W, Zhang B, Lin N, Li J, Zhou Y, Dong X, Che J. Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression. Eur J Med Chem. 2024;272:116468.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2560_CR65","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-021-01920-y","volume":"40","author":"B Li","year":"2021","unstructured":"Li B, Qi ZP, He DL, Chen ZH, Liu JY, Wong MW, Zhang JW, Xu EP, Shi Q, Cai SL, Sun D, Yao LQ, Zhou PH, Zhong YS. NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer. J Exp Clin Cancer Res. 2021;40(1):126.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"2560_CR66","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2009.12.032","volume":"140","author":"J Yuan","year":"2010","unstructured":"Yuan J, Luo K, Zhang L, Cheville JC, Lou Z. USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010;140(3):384\u201396.","journal-title":"Cell"},{"issue":"11","key":"2560_CR67","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-19-2388","volume":"80","author":"H Zhu","year":"2020","unstructured":"Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X, Cao J, Ying M, Dong X, He Q, Yang B. USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP\/TAZ. Cancer Res. 2020;80(11):2204\u201316.","journal-title":"Cancer Res"},{"issue":"3","key":"2560_CR68","doi-asserted-by":"publisher","first-page":"101088","DOI":"10.1016\/j.jbc.2021.101088","volume":"297","author":"Y He","year":"2021","unstructured":"He Y, Jiang S, Mao C, Zheng H, Cao B, Zhang Z, Zhao J, Zeng Y, Mao X. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation. J Biol Chem. 2021;297(3):101088.","journal-title":"J Biol Chem"},{"issue":"5","key":"2560_CR69","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/cas.15326","volume":"113","author":"X Liu","year":"2022","unstructured":"Liu X, Chen B, Chen J, Su Z, Sun S. Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma. Cancer Sci. 2022;113(5):1868\u201379.","journal-title":"Cancer Sci"},{"issue":"21","key":"2560_CR70","doi-asserted-by":"publisher","first-page":"13372","DOI":"10.1074\/jbc.M115.643767","volume":"290","author":"W Wang","year":"2015","unstructured":"Wang W, Huang X, Xin HB, Fu M, Xue A, Wu ZH. TRAF family Member-associated NF-\u03baB activator (TANK) inhibits genotoxic nuclear factor \u03baB activation by facilitating deubiquitinase USP10-dependent deubiquitination of TRAF6 ligase. J Biol Chem. 2015;290(21):13372\u201385.","journal-title":"J Biol Chem"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02560-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:02:43Z","timestamp":1772190163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02560-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02560-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human tissues and clinical information were collected using protocols approved by the Ethics Committee of the Guizhou Provincial People\u2019s Hospital. Written informed consent was obtained from each patient. All animal procedures used in the study were approved by the Animal Ethics Committee of Guizhou Provincial People\u2019s Hospital and conducted according to the Guidelines for the Care and Use of Laboratory Animals at Guizhou Provincial People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final version of the manuscript and approve it for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}